Start / PharmaTalkRadio / Advances in pulmonary delivery of biologics

PharmaTalkRadio

Advances in Pulmonary Delivery of Biologics

31 min • 22 januari 2025

This podcast features a panel discussion with pharma and biotech leaders about the past and future direction of pulmonary delivery of biologics. Specifically, the panelists discuss:

The benefits and costs of different formulation approaches to deliver inhaled therapeutics what needs to be developed to enable more biologics
Different device approaches including nebulizers, soft mist inhalers, dry powder inhalers and more
Factors driving new platform and therapeutic development including patient-centricity, legacy technology and time to market
Next-generation inhaled therapeutics like mRNA vaccines

To learn more about the PODD conference, please visit Drug-Delivery.org.

Senaste avsnitt

De-Risking Clinical Operations by Taking a Scaffolding Approach to Outsourcing

12 augusti | 28 min

Balancing Between Concentration and Volume when Developing Patient-Centric Biologics

12 augusti | 28 min

Directors' Talk DPHARM 2025 - AI Sessions; Part III

25 juli | 6 min

Innovations in Manufacturing to Make CAR-T More Accessible and Affordable

25 juli | 20 min

Achieving Oral Delivery of Peptides through Formulation and Molecule Design Approaches

25 juli | 29 min

Podcastbild

00:00 -00:00

Podcastbild

00:00 -00:00